In the original version of this article (1), errors were found in the z-scores in Table 3 and, consequently, the results shown in Fig. 1 and Table 5. The definition of cognitive domain impairment did not match the two-part criterion mentioned in the material and methods section (z-score ≤ −1.5 below HCs on two or more tests, or z-score ≤ −2.0 below HCs on a single test) but was based on a simple criterion (z-score ≤ −2.0 below HCs on a single test) only. Overall cognitive impairment was observed in 35% of patients with breast cancer and 15% of healthy controls. There is no change to the overall interpretation of our results and the conclusions based on adjusted models. The errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret the errors.
Skip Nav Destination
Article navigation
Correction|
November 02 2022
Correction: Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup
Cancer Epidemiol Biomarkers Prev 2022;31:2092
Received:
August 24 2022
Accepted:
August 24 2022
Online ISSN: 1538-7755
Print ISSN: 1055-9965
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
Cancer Epidemiol Biomarkers Prev (2022) 31 (11): 2092.
Article history
Received:
August 24 2022
Accepted:
August 24 2022
Related Content
Citation
Correction: Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup. Cancer Epidemiol Biomarkers Prev 1 November 2022; 31 (11): 2092. https://doi.org/10.1158/1055-9965.EPI-22-0922
Download citation file:
Advertisement
512
Views